Analyst Ratings For Amedisys (NASDAQ:AMED)
Today, Amedisys (NASDAQ:AMED) stock received an upgrade by Royal Bank of Canada from Sector Perform to Outperform.
Some recent analyst ratings include
- 3/19/2018-Royal Bank of Canada Upgrade from a “Sector Perform ” rating to a ” Outperform” rating.
- 11/21/2017-William Blair Reiterated Rating of Outperform.
- 11/10/2017-SunTrust Banks Reiterated Rating of Buy.
- 11/9/2017-Craig Hallum Reiterated Rating of Buy.
Recent Insider Trading Activity For Amedisys (NASDAQ:AMED)
Amedisys (NASDAQ:AMED) has insider ownership of 2.00% and institutional ownership of 96.71%.
- On 8/8/2017 David B Pearce, Insider, sold 1,000 with an average share price of $50.00 per share and the total transaction amounting to $50,000.00.
- On 8/3/2017 Bruce D Perkins, Director, bought 2,000 with an average share price of $46.60 per share and the total transaction amounting to $93,200.00.
- On 5/25/2017 Bruce D Perkins, Director, bought 500 with an average share price of $59.69 per share and the total transaction amounting to $29,845.00.
- On 5/12/2017 Jake L Netterville, Director, sold 10,000 with an average share price of $60.00 per share and the total transaction amounting to $600,000.00.
- On 5/10/2017 Lawrence R Pernosky, Insider, sold 11,500 with an average share price of $58.97 per share and the total transaction amounting to $678,155.00.
- On 5/9/2017 Lawrence R Pernosky, Insider, sold 11,500 with an average share price of $58.78 per share and the total transaction amounting to $675,970.00.
- On 5/8/2017 Scott G Ginn, Insider, sold 23,828 with an average share price of $58.62 per share and the total transaction amounting to $1,396,797.36.
Recent Trading Activity for Amedisys (NASDAQ:AMED)
Shares of Amedisys closed the previous trading session at with 62.560001373291016 shares trading hands.
